MuTaLig COST ACTION CA15135 st 1 Annual meeting 2016 USI Lugano(CH), JulyPoster list

First Page		Document Content
Date: 2016-07-12 08:10:41 Medicinal chemistry Signal transduction Oncology Drug discovery Tyrosine kinase receptors MTOR inhibitors Mechanistic target of rapamycin Phosphoinositide 3-kinase Quantitative structureactivity relationship C-Met		MuTaLig COST ACTION CA15135 st 1 Annual meeting 2016 USI Lugano(CH), JulyPoster list Add to Reading List Source URL: www.mutalig.eu Download Document from Source Website File Size: 374,48 KB Share Document on Facebook

	Cell Science at a Glance gradients. It is exhibited by a wide variety of cell types and involves distinct strategies that depend on the environmental conditions. For example, the migration of fibroblasts or keratinocytes DocID: 1ropC - View Document
	Atypical Protein Kinases (aPKs) Supplemental Online Material for Manning et al (Science 298:Atypical protein kinases lack sequence similarity to the ePK domain HMM profile, but have been shown experimentally t DocID: 1qVny - View Document
	JCB: ARTICLE Published November 24, 2008 Coﬁlin is a pH sensor for actin free barbed end formation: role of phosphoinositide binding DocID: 1qoAk - View Document
	First Annual Meeting BOOK OF THE ABSTRACTS COST ACTION CA15135 Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig) Università della Svizzera Italiana – USI – Lugano (CH DocID: 1qn8P - View Document
	doi:j.arr DocID: 1qiOh - View Document